A latest nerve stimulator can reduce sleep apnea in nearly two-thirds of patients according to reports published by NEJM. A battery powered implant, it can stimulate nerves to pull the tongue forward and open up the airway when breathing slows down. First launched in 2014, clinical trials show promising results with a remission of OSA in 85% of the patients. What is OSA?
Obstructive Sleep Apnea (OSA) is a serious disorder that affects nearly 1-6% of adults and 2% of children. Though OSA is more prevalent in males of the age group of 55-60, it can affect both genders and all age groups. Several other factors can contribute to OSA, like: Age Excessive weight Sinus problem Family history Allergies Gastroesophageal reflux Enlarged tonsil and tongues Deviated septum Large neck size Small jaw bone The most common…
